ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï
‰ïˆõƒƒOƒCƒ“ ‘ã•\ˆ¥ŽA
‘‰ïEŠwpW‰ï
Šw‰ïŽ
’芼
Κ
—˜‰v‘Š”½
–ðˆõ\¬
Ž––±‹ÇˆÄ“à
‹lŽ{݈ꗗ
ŠÖ˜AƒŠƒ“ƒN

@ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰ïŽ‚Ö–ß‚é
<< ‘O‚̃y[ƒW‚Ö–ß‚é

‘æ70‰ñŠwpW‰ïiº˜a60”N10ŒŽ27“új

yˆê”ʉ‰‘èz
“à•ª”å
ŒŒ’†ƒÀ-endrophinCƒÀ-lipotropin‚Ì“ú“à•Ï“®


¬’r@´•F, ¬”¦@Œ÷, ¡ì@Ms, —Ñ@•ŸŸ, –I‰®@ˈê
ŽœŒb‰ïˆã‰È‘åŠw, Œñ¬•a‰@



“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, (43) 111-111, 1986


ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ïŽ––±‹Ç@§102-0083 “Œ‹ž“sç‘ã“c‹æ’¬4-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“à
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï